Efficacy of Memantine on Cognitive Performance of Patients Under Electro Convulsive Therapy

Not Applicable

• Conditions: Condition 1: Mental and behavioural disorders. Condition 2: Mental and behavioural disorders. Condition 3: Mental and behavioural disorders. Condition 4: Mental and behavioural disorders. Condition 5: Mental and behavioural disorders. Condition 6: Mental and behavioural disorders.; Schizophrenia, schizotypal and delusional disorders; Mood [affective] disorders; Neurotic, stress-related and somatoform disorders; F60-F61-F62-F63-F64-F65-FF66-F67-F68-F69; Unspecified mental disorder; F20-F21-F2; F30-F31-F3; F40-F41-F4; Disorders

• Registration Number: IRCT2013072314122N1
• Lead Sponsor: Kurdistan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Other
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

This study was done on patients in Sanandaj in 1392 in Qods hospital admissions and physician elected to receive ECT.
Patients between 60-18 years of age who are candidates for ECT; Patient or legal guardian to sign an informed consent form; Number of ECT sessions is between 4 to 12 sessions; Location is the city of Sanandaj.
Exclusion criteria: Abuse or dependence on alcohol and drugs during the 3 months prior to admission (excluding nicotine or caffeine); Proven kidney disease (Renal Failure proven); Epilepsy; Mental Retardation based on clinical evaluation Resident Project; Delirium, Dementia and Cognitive disorders; Pregnancy and lactation; Use of Memantine than 3 months prior to admission; Patients who are receiving Thiazide diuretics; History of allergic symptoms and side effect with Memantine.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cognitive function. Timepoint: ECT prior to and after completion of the. Method of measurement: MMSE and Digit Span Test.

Secondary Outcome Measures

Name	Time	Method
Duration of the sizure. Timepoint: During ECT sessions. Method of measurement: View and review patient records.;Delayed onset sizure. Timepoint: Electric convulsive therapy during hospital stay. Method of measurement: patients visit and file check.